🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the service has taken down violative material and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.

Digital Trading Activities

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or administering at home.

After moments of joining one group, a vendor posted contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.

Product Information and Pricing

Inside these groups, messages show dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly serious health risks”.